AC
NTGN

Armistice Capital’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Armistice Capital’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,050,000
Closed -$2.77M – 97
2020
Q1 		$2.77M Buy
+1,050,000
New +$1.72M 0.17% 69

Armistice Capital's NTGN Position: Q2 2020 in Review

Armistice Capital sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 1,050,000 shares — an estimated $2.77M sold.

Armistice Capital first reported a position in NTGN in Q1 2020 and held it in 1 quarter. The position peaked at $2.77M in Q1 2020. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

  • Armistice Capital reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Armistice Capital sold 1,050,000 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $2.77M.
  • Armistice Capital first reported a position in Neon Therapeutics, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Armistice Capital's Neon Therapeutics, Inc. Common Stock position peaked at $2.77M in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Armistice Capital's 13F filing for Q2 2020, filed 14 Aug 2020.